A high-throughput test to detect C.E.R.A. doping in blood

Journal of Pharmaceutical and Biomedical Analysis

Volumn 50, Issue 5, 2009, Pages 954-958

  Lamon, Séverine ^a   Giraud, Sylvain ^a   Egli, Léonie ^a   Smolander, Jessica ^b   Jarsch, Michael ^c   Stubenrauch, Kay Gunnar ^c   Hellwig, Alice ^d   Saugy, Martial ^a   Robinson, Neil ^a  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c ROCHE DIAGNOSTICS GMBH   (Germany)

^d MicroCoat GmbH   (Germany)

Author keywords

Blood doping; C.E.R.A.; ELISA; Erythropoietin

Indexed keywords

CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR;

ADULT; ARTICLE; CONTROLLED STUDY; DOPING; DRUG ABUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH THROUGHPUT SCREENING; HUMAN; ISOELECTRIC FOCUSING; MALE; NORMAL HUMAN; PILOT STUDY; PRIORITY JOURNAL; REPRODUCIBILITY;

ADULT; DOPING IN SPORTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; HUMANS; ISOELECTRIC FOCUSING; MALE; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION;

EID: 70349183432     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.06.038     Document Type: Article

References (18)

1. Donnelly S. Am. J. Kidney Dis. 38 (2001) 415-425
2. Fisher J.W. Exp. Biol. Med. (Maywood) 228 (2003) 1-14
3. Jelkmann W. Physiol. Rev. 72 (1992) 449-489
4. Macdougall I.C. Curr. Hematol. Rep. 4 (2005) 436-440
5. Wattendorf U., and Merkle H.P. J. Pharm. Sci. (2008)
6. Macdougall I.C. Semin. Nephrol. 26 (2006) 313-318
7. Berglund B., and Ekblom B. J. Intern. Med. 229 (1991) 125-130
8. Verbrugge D.J., and Goodnough L.T. Scand. J. Clin. Lab. Invest. 54 (1994) 55-59
9. Lasne F., Martin L., Crepin N., and de Ceaurriz J. Anal. Biochem. 311 (2002) 119-126
10. Lasne F., and deCeaurriz J. Nature 405 (2000) 635
11. Lasne F. J. Immunol. Methods 276 (2003) 223-226
12. Lasne F., Martin L., Martin J.A., and de C.J. Haematologica 94 (2009) 888-890
13. Fishbane S., Pannier A., Liogier X., Jordan P., Dougherty F.C., and Reigner B. J. Clin. Pharmacol. 47 (2007) 1390-1397
14. Macdougall I.C., Robson R., Opatrna S., Liogier X., Pannier A., Jordan P., Dougherty F.C., and Reigner B. Clin. J. Am. Soc. Nephrol. 1 (2006) 1211-1215
15. Barclay P.G., Fischer E.R., and Harris D.C. Clin. Nephrol. 40 (1993) 277-280
16. Breidbach A., Catlin D.H., Green G.A., Tregub I., Truong H., and Gorzek J. Clin. Chem. 49 (2003) 901-907
17. Lamon S., Robinson N., Mangin P., and Saugy M. Clin. Chim. Acta 379 (2007) 145-149
18. World Anti-Doping Agency (WADA). International Standard for Laboratories v 5.0, Montreal, 2008.